Biological Sample Markers with Covalent Linkers for Robust Assembly

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing markers for biological samples, such as those used in fluorescent microscopy, are complex to produce due to individual assembly of parts, leading to inefficiencies and reduced robustness, with reversible attachments resulting in shorter shelf life.

Innovation Solution

A marker comprising an affinity reagent, a linker oligonucleotide, and a labelling moiety, where the linker oligonucleotide is covalently attached to both, enabling efficient and robust assembly without hybridization, using methods like click chemistry and ligase-mediated ligation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If individual parts of the marker are assembled through hybridization, then the marker can be produced modularly, but the attachment becomes reversible and less robust

Engineering Contradiction:
Improvemodular assemblyVSAvoidattachment robustness
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent replaces the mechanical hybridization-based attachment system with a covalent bonding system. Specifically, it uses click chemistry (copper-catalyzed azide-alkyne cycloaddition) to form irreversible covalent bonds between the affinity reagent and the oligonucleotide linker, and between the oligonucleotide and the label. This substitution of bonding mechanism maintains modular assembly capability while dramatically improving attachment robustness and marker stability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Adaptability or versatility

If individual parts are assembled step-by-step, then the marker can be constructed with specific components, but the production process becomes complex and time-consuming

Engineering Contradiction:
Improvecomponent selectionVSAvoidassembly process
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-functionalizing the affinity reagent with an azide group and the oligonucleotide linker with an alkyne group before assembly. This pre-preparation of reactive groups enables a single-step click chemistry conjugation reaction, simplifying the overall process while maintaining the ability to selectively choose different affinity reagents, linkers, and labels for specific applications.

Inventive Principle:
Principle #10Preliminary action

3Ease of manufacture

If traditional marker assembly methods are used, then individual components can be optimized separately, but reaction losses and purification losses increase

Engineering Contradiction:
Improvecomponent optimizationVSAvoidreaction and purification losses
Core Design Contradiction:
Ease of manufactureVSLoss of substance

Solution Approach 1:

The patent replaces traditional step-by-step chemical conjugation methods with click chemistry, which offers high reaction efficiency and specificity. The copper-catalyzed azide-alkyne cycloaddition proceeds with near-quantitative yield and minimal side reactions, eliminating the need for extensive purification steps. This substitution dramatically reduces both reaction losses and purification losses while maintaining the ability to optimize individual components separately.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution allows for efficient, robust, and bright markers to be generated with reduced losses, facilitating easy assembly and analysis of biological samples without the need for separation or purification steps.

Implementation Method 1

The at least one linker oligonucleotide is attached to the affinity reagent, and the at least one labelling moiety is attached to the at least one linker oligonucleotide

Methodology Applied
Scientific EffectClick chemistry: Chemical Bonding

Implementation Method 2

using methods like click chemistry and ligase-mediated ligation

Methodology Applied
Scientific EffectLigase-mediated ligation: Enzyme

Data Source

PatentUS20250251392A1Marker for analysing a biological sample
Publication Date: 2025.08.07 LEICA MICROSYSTEMS CMS GMBH
  • US20250251392A1 patent drawing
  • US20250251392A1 patent drawing
  • US20250251392A1 patent drawing

AI summary

A marker for analysing a biological sample includes an affinity reagent, at least one labelling moiety, and at least one linker oligonucleotide. The at least one linker oligonucleotide is attached to the affinity reagent, and the at least one labelling moiety is attached to the at least one linker oligonucleotide.